<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0191294.ref032">
 <label>32</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Malati</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Rosenfeld</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Mowafy</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Rittmiller</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Kuritsky</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Crowley</surname>
   <given-names>J</given-names>
  </name>. 
  <article-title>Dealing with large-scale supply lines when introducing new regimens</article-title>. 
  <source>Curr Opin HIV AIDS</source>. 
  <year>2017</year>;
  <volume>12</volume>(
  <issue>4</issue>): 
  <fpage>408</fpage>â€“
  <lpage>413</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/COH.0000000000000387" xmlns:xlink="http://www.w3.org/1999/xlink">10.1097/COH.0000000000000387</ext-link>
  </comment>
  <?supplied-pmid 28562507?>
  <pub-id pub-id-type="pmid">28562507</pub-id>
 </mixed-citation>
</ref>
